Biblio
Export 2651 results:
Author Title [ Type
Filters: First Letter Of Last Name is S [Clear All Filters]
“Subjective Cognitive Decline: Is a Resilient Personality Protective Against Progression to Objective Cognitive Impairment? Findings from Two Community-Based Cohort Studies.”, J Alzheimers Dis, vol. 89, no. 1, pp. 87-105, 2022.
, “Subjective Cognitive Decline: Is a Resilient Personality Protective Against Progression to Objective Cognitive Impairment? Findings from Two Community-Based Cohort Studies.”, J Alzheimers Dis, vol. 89, no. 1, pp. 87-105, 2022.
, “Subjective Cognitive Decline: Is a Resilient Personality Protective Against Progression to Objective Cognitive Impairment? Findings from Two Community-Based Cohort Studies.”, J Alzheimers Dis, vol. 89, no. 1, pp. 87-105, 2022.
, “Subjective Cognitive Decline and APOE ɛ4: A Systematic Review.”, J Alzheimers Dis, vol. 65, no. 1, pp. 303-320, 2018.
, “Subjective Cognitive Complaints in Cognitively Healthy Older Adults and Their Relationship to Cognitive Performance and Depressive Symptoms.”, J Alzheimers Dis, vol. 59, no. 3, pp. 871-881, 2017.
, “Subclinical Doses of ATP-Sensitive Potassium Channel Modulators Prevent Alterations in Memory and Synaptic Plasticity Induced by Amyloid-β.”, J Alzheimers Dis, vol. 57, no. 1, pp. 205-226, 2017.
, “Structural Connectivity Alterations Along the Alzheimer's Disease Continuum: Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-β and Tau.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1575-1587, 2018.
, “Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.”, J Alzheimers Dis, vol. 74, no. 3, pp. 747-757, 2020.
, “Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.”, J Alzheimers Dis, vol. 74, no. 3, pp. 747-757, 2020.
, “Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.”, J Alzheimers Dis, vol. 74, no. 3, pp. 747-757, 2020.
, “Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.”, J Alzheimers Dis, vol. 74, no. 3, pp. 747-757, 2020.
, “Structural Anatomical Investigation of Long-Term Memory Deficit in Behavioral Frontotemporal Dementia.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1887-1900, 2018.
, “Strong Impact of Chronic Cerebral Hypoperfusion on Neurovascular Unit, Cerebrovascular Remodeling, and Neurovascular Trophic Coupling in Alzheimer's Disease Model Mouse.”, J Alzheimers Dis, vol. 52, no. 1, pp. 113-26, 2016.
, “Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer's Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?”, J Alzheimers Dis, vol. 57, no. 4, pp. 1017-1039, 2017.
, “Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer's Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?”, J Alzheimers Dis, vol. 57, no. 4, pp. 1017-1039, 2017.
, “Streptozotocin Induces Mild Cognitive Impairment at Appropriate Doses in Mice as Determined by Long-Term Potentiation and the Morris Water Maze.”, J Alzheimers Dis, vol. 54, no. 1, pp. 89-98, 2016.
, “Stratification by Genetic and Demographic Characteristics Improves Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers in Rapidly Progressive Dementia.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1385-1393, 2016.
, “Stratification by Genetic and Demographic Characteristics Improves Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers in Rapidly Progressive Dementia.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1385-1393, 2016.
, “Strategies for improving memory: a randomized trial of memory groups for older people, including those with mild cognitive impairment.”, J Alzheimers Dis, vol. 49, no. 1, pp. 31-43, 2016.
, “Strategies for improving memory: a randomized trial of memory groups for older people, including those with mild cognitive impairment.”, J Alzheimers Dis, vol. 49, no. 1, pp. 31-43, 2016.
, “Stimulating the Activity of Amyloid-Beta Degrading Enzymes: A Novel Approach for the Therapeutic Manipulation of Amyloid-Beta Levels.”, J Alzheimers Dis, vol. 54, no. 3, pp. 891-895, 2016.
, “Stimulating the Activity of Amyloid-Beta Degrading Enzymes: A Novel Approach for the Therapeutic Manipulation of Amyloid-Beta Levels.”, J Alzheimers Dis, vol. 54, no. 3, pp. 891-895, 2016.
, “Stem Cell Therapy for Alzheimer's Disease: A Review of Recent Clinical Trials.”, J Alzheimers Dis, vol. 54, no. 3, pp. 879-889, 2016.
, “Standardized Uptake Value Ratio-Independent Evaluation of Brain Amyloidosis.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1437-1457, 2016.
, “The Standardized Extract of Centella asiatica and Its Fractions Exert Antioxidative and Anti-Neuroinflammatory Effects on Microglial Cells and Regulate the Nrf2/HO-1 Signaling Pathway.”, J Alzheimers Dis, vol. 99, no. s1, pp. S119-S138, 2024.
,